Browse diseases

…ess, health benefits, cost and implementation of the Paediatric HIV disclosure intervention, Sankofa 2, is posed to offer valuable …

…t, the XGBoost model showed superior performance for predicting AIDS progression. The proposed nomogram may serve as a practical too…

…rtner RERI: 0.44 (95% CI 0.02 to 0.86).Conclusions We show that HIV and diabetes exhibit syndemic properties, indicated by geospati…

…adolescents and youth living with HIV/AIDS (AYLHIV), preventing HIV disease progression and improving quality of life. The objectiv…

…ad used tobacco during the ban and quit afterwards. People with HIV were more likely than people without HIV to stop during the ban…

…his population. While Mental Health Disorders (MHDs) can impede HIV care and promote adverse health outcomes, there is limited lite…

…e microbiological results and clinical symptoms, the underlying HIV infection, the potential difficulties with adherence to other r…

…seeks to determine incidence, comorbidities and drivers for new HIV infections to develop, test and validate a risk prediction mode…

…ran Africa, young people are disproportionately affected by the HIV epidemic and are more often the recipients of HIV testing servi…

…erviews with 23 staff members across five ED sites in very high HIV prevalence areas were analysed thematically, informed by Normal…

…ion new curable infections (chlamydia, gonorrhoea, syphilis and trichomoniasis) occur among adults aged 15–49 years annually, alongside lifelo…

…acting injectable cabotegravir (CAB-LA) is a promising new PrEP HIV prevention option. However, little is known about oPrEP users’ …